GlobalData on MSN

Marea reports positive Phase I results for MAR002 trial in acromegaly

Single-ascending doses of MAR002 showed a favourable tolerability and safety profile with no drug-related safety signals ...
Business Wire

Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress

MAR001, a first-in-class monoclonal antibody targeting ANGPTL4, demonstrated approximately 53% placebo-adjusted mean reduction in remnant cholesterol and placebo-adjusted mean reduction in ...
The Hollywood Reporter

New York’s Marea Restaurant Is Heading to Beverly Hills (Exclusive)

The power dining spot on Central Park South known for its coastal Italian menu and celebrity guests will debut its first West Coast location in 2024 at 430 N. Camden Drive. By Degen Pener Deputy ...
Business Wire

Marea Therapeutics Launches with $190 Million to Accelerate a New Generation of Medicines for Cardiometabolic Diseases

Leveraging large-scale human genetics to advance clinical-stage pipeline of first-in-class treatments that target critical, unaddressed and genetically validated causes of cardiometabolic diseases ...
FierceBiotech

Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines

Marea Therapeutics has emerged with $190 million, a mid-stage clinical program and a plan to harness genetics and pioneer “the next frontier” of cardiometabolic medicines. Marea was incubated by Third ...